FDA Inspection
Surgi-Care, Inc.Surgi-Care, Inc. – FDA Inspection, Apr 11, 2013
Record Details
This FDA Inspection record concerns Surgi-Care, Inc., with an inspection on April 11, 2013, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Surgi-Care, Inc.
- Inspection Date
- April 11, 2013
- Product Type
- Biologics
View Company Profile
ID · b75720de-ad2b-4913-a3a3-0876cc932e4b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 828785
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
FDA Citations
1- 21 CFR 1271.265(e)Procedures and release criteria
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Surgi-Care, Inc.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| February 10, 2020 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| January 12, 2017 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| March 10, 2015 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| January 14, 2009 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Surgi-Care, Inc.
- FDA Inspection 1120374 - 2020-02-10
- FDA Inspection 997637 - 2017-01-12
- FDA Inspection 920502 - 2015-03-10
- FDA Inspection 638764 - 2009-01-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.